News
The FDA approved Sarepta’s gene therapy for Duchenne, and later expanded it, despite clinical trials that failed to meet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback